Logo
x

Search

Subscribe Now

Children

Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Expanded Use to Treat Paroxysmal Nocturnal Haemoglobinuria

Alexion's Ultomiris (ravulizumab) Receives EC's Approval for Expanded Use to Treat Paroxysmal Nocturnal Haemoglobinuria

  • September 3, 2021
Sanofi and Regeneron's Dupixent Meets All Endpoints in P-III Study in Children with Atopic Dermatitis

Sanofi and Regeneron's Dupixent Meets All Endpoints in P-III Study in Children with Atopic Dermatitis

  • August 30, 2021
Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

Alexion's Ultomiris (ravulizumab) Receives CHMP's Positive Opinion Recommending its Approval for Children and Adolescents with PNH

  • July 26, 2021
Janssen Reports Submission of NDA to the US FDA for Xarelto (rivaroxaban) to Prevent and Treat Blood Clots in Children

Janssen Reports Submission of NDA to the US FDA for Xarelto (rivaroxaban) to Prevent and Treat Blood Clots in Children

  • June 24, 2021
J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children

J&J Vision Collaborates with Menicon to Offer Contact Lenses for Managing the Progression of Myopia in Children

  • April 7, 2021
The US FDA Approves New Indication and Formulation for Astellas' Myrbetriq

The US FDA Approves New Indication and Formulation for Astellas' Myrbetriq

  • March 26, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.